Pharma Archives - Feedback

Pharma

The US Food and Drug Administration, which conducted an inspection of a facility of Aurobindo Pharma at Pashamylaram in Medak district. procedures designed to prevent microbiological contamination of drug products purporting to be sterile have not been established and followed in the unit-IV of the drug company. https://www.business-standard.com/article/pti-stories/lacunae-in-aurobindo-pharma-s-facility-says-fda-report-119022700733_1.html

TPG Growth will invest $30 million in Solara Active Pharma, a manufacturer of active pharmaceutical ingredients (API) with a network of clients including several global generic companies in the US and Europe. The investment also marks TPG Growth’s first investment in India focused on life sciences. https://www.business-standard.com/article/companies/tpg-enters-india-s-pharma-market-with-30-mn-investment-in-solara-active-119020400233_1.html

Health-tech platform Medlife is planning to expand its presence in the retail pharmacy segment by opening around 750 pharmacies across the country in two years. The company, which is a leading player in the online pharmacy segment, is mainly looking at acquisitions to achieve the target. https://www.business-standard.com/article/companies/medlife-plans-to-open-750-retail-pharmacies-across-india-by-2020-end-119011300096_1.html

US-drug maker Pfizer will be shutting down two of its facilities in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing non-viability of operations. The closures will affect 1700 employed at both locations of the company which has a total of five manufacturing sites across the country. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pfizer-to-stop-manufacturing-in-its-chennai-and-aurangabad-facilities/articleshow/67456313.cms

Drug major Sun Pharma has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe. The acquisition of 100 % shares of Pola Pharma Inc Japan by the company’s wholly owned subsidiary has been concluded. https://www.business-standard.com/article/companies/sun-pharma-acquires-japan-s-pola-pharma-to-expand-in-dermatology-segment-119010300702_1.html

Bristol-Myers Squibb Co would buy Celgene Corp for about $74 billion, combining two of the world’s largest cancer drug businesses in the biggest pharmaceutical deal ever. Both Bristol-Myers and Celgene face separate challenges, and some Wall Street analysts questioned whether the combination – which the companies said would create $2.5 billion in cost savings and […]

The foundation stone of a 136-bed hospital building in the premises of Coronation Hospital at Curzon Road. Rawat also announced a CT scan, X-ray, blood bank and an emergency ward with 16 beds for the hospital. The hospital is set to open to public on June 23, 2020. It will be built in an area […]

Healthcare sector may see further consolidation in 2019 with tightening of regulatory environment set to make it difficult for small players to stay afloat in a highly competitive market. Industry players also expect more partnerships in the new year between public and private sector in the healthcare space, which they feel is ‘under-invested’. Already, Malaysia’s […]

Hyderabad-headquartered Aurobindo Pharmaceuticals, which draws around 47 per cent of its revenues from the US, is a late entrant in the biosimilars and injectables space. In the second quarter, AuroMedics, the company’s injectable business, witnessed an 8 per cent year-on-year growth to $50 million. The company has already filed a total of 104 injectables, abbreviated […]

MMTC Ltd, the state owned trading entity, aims to commence exports of engineering goods and pharmaceutical products from Q1 of next fiscal. The company is looking at transactions in new commodities and go beyond its forte in trade of bullion and major bulk minerals like iron ore and chromite. MMTC is awaiting award of drug […]